COVID-19 Delta Variant Q & A with Drs. Cindy Gay and David Wohl
Cindy Gay, MD, and David Wohl, MD, answer questions about the COVID-19 Delta variant, vaccine efficacy and mRNA vaccine safety.
UNC to Lead $15 Million Statewide COVID-19 Surveillance Program Funded by NC Policy Collaboratory
The surveillance program, led by UNC SOM’s Dirk Dittmer, PhD, Amir Barzin, DO, and Gillings’ Audrey Pettifor, PhD, will collect, sequence, and share data on SARS-CoV-2 samples from across the…
Wohl Pens Op-Ed to Encourage Vaccination against Delta Variant
Regardless of their rationales, unvaccinated people serve as kindling for the delta fire. David Wohl, MD, wrote an op-ed in the Raleigh News & Observer about current COVID-19 trends.
COVID Rapid Response Grants Support 22 Communities Nationwide to Improve Health Equity
Clinical Scholars awarded $298,000 in COVID rapid response grants for 22 projects nationwide. The national leadership program for health care providers pivoted program funds which helped nearly 10,000 people plus…
Covid-19 / Coronavirus, Diversity, Equity and Inclusion, News, North Carolina, School of Medicine, Social Medicine, Strategic Plan, Vital Signs, Wellness
Schwarts, Walker publish NEJM article on COVID-related Multisystem Inflammatory Syndrome
Stephanie Schwartz, MD, and Tracie Walker, MD, in Pediatric Critical Care Medicine, published in the New England Journal of Medicine: “Multisystem Inflammatory Syndrome in Children – Initial Therapy and Outcomes.”
Clinical Research, Covid-19 / Coronavirus, Pediatrics And Children's Health, Vital Signs
UNC Researchers Lead Study of Diabetes Treatment of Severely Ill COVID-19 Patients
Led by John Buse, MD, PhD, and Anna Kahkoska, MD, PhD, this analysis showed that GLP1-RA and SGLT2i medication use for type 2 diabetes of hospitalized COVID-19 patients was associated…
‘Nanodecoy’ Therapy Binds and Neutralizes SARS-CoV-2 Virus
NC State researchers led by Ke Cheng, PhD, created a therapeutic approach that mimics the receptor that the virus binds to and then traps the virus before it infect cells….
Newly Released Trial Results Show Novavax COVID-19 Vaccine Highly Effective
Results from the Novavax phase III clinical trial for its COVID-19 vaccine show an overall efficacy of 90%, and demonstrate 100% protection against moderate and severe disease. The study enrolled…
Announcements, Covid-19 / Coronavirus, News, Research, School of Medicine, Vital Signs
Two COVID-19 Vaccines Show Safety, Strong Immunity in Infant Model
This pre-clinical research offers evidence that vaccinating young children could help prevent the spread of COVID-19, limit disease severity, and achieve herd immunity.
COVID-19 Simulation Shows Importance of Continued Safety Efforts During Vaccine Distribution
A team of researchers led by UNC School of Medicine’s Mehul Patel, PhD, has produced a mathematical simulation that evaluates how many COVID-19 cases could be avoided in North Carolina…
Covid-19 / Coronavirus, News, Research, School of Medicine, Vital Signs
Meet the Team: UNC Health’s COVID Vaccination Mobile Unit
UNC Health’s COVID Vaccination Mobile Unit continues to meet the need in helping underserved populations get vaccinated. So far, the unit has been able to vaccinate about 1,400 patients since…
Center for Excellence in Community Mental Health supporting Covid-19 vaccinations among the most vulnerable.
The UNC Center for Excellence in Community Mental Health is utilizing technology and outreach efforts to provide their patients with the COVID-19 vaccine.
Covid-19 / Coronavirus, North Carolina, Psychiatry And Mental Health, School of Medicine, Vital Signs
Cancer Drug Shows Potential Against Pseudo SARS-CoV-2 in Lab Tests
The UNC School of Medicine labs of Pengda Liu, PhD, and Guochun Jiang, PhD, led work to show how the drug lenalidomide can disrupt the pseudo-coronavirus’s ability to infect human…
UNC-Chapel Hill COVID-19 Research Output & Collaboration Analysis
Research contributing to discoveries associated with COVID-19 has been growing on the UNC campus over the past year. To help increase visibility of this integral research and illustrate the extensive…
Covid-19 / Coronavirus, Faculty, Infectious Diseases, News, Research, School of Medicine, Vital Signs
UNC Football Coach Mack Brown Gets the COVID-19 Vaccine. You should too.
If you haven’t been vaccinated, please go to www.YourShot.org.
UNC’s Novavax COVID-19 Vaccine Clinical Trial Enrolling Adolescents
Vaccinating children against COVID-19 is critical to ending this pandemic, and you can help. UNC’s trial site will begin enrolling children 12-17 years of age on May 6.
Covid-19 / Coronavirus, News, Research, School of Medicine, Vital Signs
Alleviating the Vaccine Gap: A Community Health Worker’s Contribution
Brandon Teal, a UNC Health Alliance community health worker, shares his experience contributing to UNC Health’s equitable vaccine distribution mission.
Women’s Health Education Center Releases COVID Vaccine Video in Spanish
The Women’s Health Education Center (WHEC) at UNC Medical Center released a COVID vaccine video in Spanish, which includes information about vaccination and pregnancy/lactation; possible side effects; and recommendations on…
UNC Health joins nationwide campaign with other leading US hospitals to promote COVID-19 vaccination
Led by Cleveland Clinic and Mayo Clinic, the campaign “Get the Vaccine to Save Lives,” is designed to reassure the public that vaccines are safe, effective and necessary to achieve…
UNC Joins National Effort to Study Allergic Reactions to COVID mRNA Vaccines
UNC School of Medicine’s David Peden, MD, is the UNC site principal investigator of the NIH-sponsored study, and Scott Commins, MD, PhD, is co-PI. Participants can now enroll at UNC-Chapel…
